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Abstract
Background: Glucocorticoid-induced leucine zipper (GILZ) is a mediator of the anti-inflammatory activities of
glucocorticoids. However, GILZ deletion does not impair the anti-inflammatory activities of exogenous glucocorticoids in
mice arthritis models and GILZ could also mediate some glucocorticoid-related adverse events. Osteoarthritis (OA) is a
metabolic disorder that is partly attributed to adipokines such as leptin, and we previously observed that glucocorticoids
induced leptin secretion in OA synovial fibroblasts. The purpose of this study was to position GILZ in OA through its
involvement in the anti-inflammatory activities of glucocorticoids and/or in the metabolic pathway of leptin induction.
The influences of mineralocorticoids on GILZ and leptin expression were also investigated.
Methods: Human synovial fibroblasts were isolated from OA patients during knee replacement surgery. Then, the cells
were treated with a glucocorticoid (prednisolone), a mineralocorticoid (aldosterone), a glucocorticoid receptor (GR)
antagonist (mifepristone), a selective glucocorticoid receptor agonist (Compound A), mineralocorticoid receptor (MR)
antagonists (eplerenone and spironolactone), TNF-α or transforming growth factor (TGF)-β. Cells were transfected with
shRNA lentiviruses for the silencing of GILZ and GR. The leptin, IL-6, IL-8 and matrix metalloproteinase (MMP)-1 levels
were measured by ELISA. Leptin, the leptin receptor (Ob-R), GR and GILZ expression levels were analyzed by western
blotting and/or RT-qPCR.
Results: (1) The glucocorticoid prednisolone and the mineralocorticoid aldosterone induced GILZ expression
dose-dependently in OA synovial fibroblasts, through GR but not MR. Similar effects on leptin and Ob-R were
observed: leptin secretion and Ob-R expression were also induced by prednisolone and aldosterone through GR;
(2) GILZ silencing experiments demonstrated that GILZ was involved in the glucocorticoid-induced and
mineralocorticoid-induced leptin secretion and Ob-R expression in OA synovial fibroblasts; and (3) GILZ inhibition
did not alter the production of pro-inflammatory cytokines by OA synovial fibroblast or the anti-inflammatory
properties of glucocorticoids.
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Conclusions: The absence of GILZ prevents corticoid-induced leptin and Ob-R expression without affecting the
anti-inflammatory properties of glucocorticoids in OA synovial fibroblasts. Mineralocorticoids also induce leptin
and Ob-R expression through GILZ.
Keywords: Leptin, GILZ, Osteoarthritis, Glucocorticoids, Mineralocorticoids, Synovial fibroblasts
Background
The glucocorticoid-induced leucine zipper (GILZ) protein
is an intracellular protein that is induced by glucocorti-
coids. Recent studies have highlighted a major role of
GILZ in the anti-inflammatory activities of glucocorti-
coids. GILZ inhibits the nuclear factor (NF)-kB pathway
in human macrophage cells, epithelial respiratory cells
and T lymphocytes [1–4]. GILZ also promotes T helper
(Th)17 cell polarization toward a regulatory mesenchymal
stem cell phenotype in arthritis [5], and it even displays
additional functions in depression [6] and spermatogen-
esis [7]. Further, GILZ is expressed by synovial fibroblasts
and is an endogenous anti-inflammatory mediator in
rheumatoid arthritis [8]. Ngo et al. have reported the anti-
inflammatory activity of exogenous GILZ in the treatment
of collagen-induced arthritis [9]. However, GILZ depletion
does not always impair the anti-inflammatory activities of
exogenous glucocorticoids [9, 10]. Thus, evidence of a
central role of GILZ as an anti-inflammatory agent is lack-
ing and controversial, and requires further exploration,
specifically with respect to osteoarthritis (OA), for which
intra-articular glucocorticoid injections are used as a
symptomatic treatment.
OA is characterized by cartilage breakdown, subchon-
dral bone thickening, osteophyte formation and synovial
inflammation. It was first considered to be a degenera-
tive disease caused by aging and mechanical stress.
However, obesity has also been identified as a risk factor
for digital OA [11] (involving non-weight-bearing joints),
suggesting a metabolic influence on OA pathogenesis
[12]. The metabolic origin of OA can be partly attributed
to the presence of adipokines, such as leptin [13–15],
which has a well-established link with OA. For example,
the synovial and serum leptin levels have both been cor-
related with the radiologic score for OA severity [14];
the leptin concentration in synovial fluid has been corre-
lated with body mass index (BMI) [16]; higher leptin ex-
pression has been detected in vitro in OA cartilage
tissues compared with healthy control tissues [13]; and
obesity due to impaired leptin signaling in mice does not
lead to OA, in contrast to what is observed in obesity
due to overfeeding [15].
In vitro, leptin has pro-inflammatory properties; e.g., it
induces interleukin-6 (IL-6) expression in synovial fibro-
blasts [17] and matrix metalloproteinase (MMP) produc-
tion in human osteoarthritic cartilage [18]. We have
previously demonstrated that OA synovial fibroblasts
spontaneously produce leptin in vitro [19], suggesting
their contribution to the intra-articular leptin level. Ex-
pression of leptin and its receptor (Ob-R) are strongly
enhanced by glucocorticoids in OA synovial fibroblasts.
Furthermore, we have previously demonstrated the in-
volvement of transforming growth factor-β (TGF-β) sig-
naling; prednisolone induces leptin secretion through
the ALK1-Smad1/5 pathway, while TGF-β1 suppresses
prednisolone-induced leptin secretion through ALK5-
Smad2/3 [20].
Glucocorticoids bind to their native receptor, gluco-
corticoid receptor (GR), and mediate their effects
through two different pathways: the “trans-repression”
and the “trans-activation” [21]. Although this duality is
more complex and although these two pathways are less
separate than initially described, trans-repression is usu-
ally associated with anti-inflammatory effects, and trans-
activation is typically correlated with adverse metabolic
events. Selective glucocorticoid receptor agonists (SEG-
RAs) are GR agonists that are known to have a better
benefit-risk ratio than glucocorticoids and do not induce
adverse metabolic events. They only activate the trans-
repression pathway without modulating trans-activation
[21]. We previously observed that SEGRA compound A
(CpdA), which is known to have a better benefit-risk ra-
tio than glucocorticoids [22], does not induce leptin se-
cretion or Ob-R expression [23]. Therefore, regarding
the detrimental role of leptin in OA, we hypothesized
that leptin and Ob-R induction could result from
glucocorticoid-associated adverse events. However, the
underlying mechanisms remain to be elucidated, and the
link between GILZ and leptin is unknown.
GR is the native receptor of glucocorticoids. However,
glucocorticoids can also act through mineralocorticoid
receptor (MR) [24]. Conversely, mineralocorticoids act
through GR [25] in addition to their native receptor,
MR. Recent studies have suggested that components of
metabolic syndrome are associated with abnormal aldos-
terone physiology [26]. Furthermore, leptin secretion is in-
creased after aldosterone exposure in brown adipose
tissue [27]. Of interest, GILZ expression is also induced by
mineralocorticoids, e.g., its involvement in epithelial chan-
nel induction in the kidneys occurs through MR [28].
Therefore, in the present study, we investigated the
following issues: (1) whether GILZ expression is also
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induced by mineralocorticoids in human OA synovial fi-
broblasts and whether this effect is dependent on either
GR or MR; (2) whether GILZ and leptin expression are
closely correlated; and (3) whether GILZ plays a central
role as an anti-inflammatory agent in this type of cell.
Methods
Human synovial fibroblasts and cell culturing
Synovial tissue was obtained from patients with OA dur-
ing knee replacement surgery. All patients (n = 16) pre-
sented with symptomatic knee OA without inflammatory
disease or cancer. None of the patients had received oral
or intra-articular glucocorticoids for at least one year. The
mean patient age was 71 (58–82) years, and the mean
BMI was 26.3 (22.2–32.7) kg/m2. Seven patients were fe-
male (44 %).
Synovial fibroblasts were isolated as previously de-
scribed [19]. Cells were cultured in DMEM (Cambrex
Bio Science, USA) with 10 % FBS (Lonza, Switzerland),
L-glutamine (2 mM), streptomycin (100 mg/mL) and
penicillin (100 U/mL) (BioWhittaker, USA). A total of
5 × 105 synovial fibroblasts/well were plated in 24-well
plates (BD Biosciences, USA). Cells were used at pas-
sages 3–7 and were stimulated with the glucocorticoid
prednisolone (1 μM, unless stated otherwise), the min-
eralocorticoid aldosterone (1 and 10 μM, unless stated
otherwise), the GR antagonist mifepristone (5 μM), the
MR antagonist eplerenone (5 μM), the MR antagonist
spironolactone (5 μM) (Sigma-Aldrich, USA), the
SEGRA CpdA (1 and 10 μM) (Santa Cruz Biotechnol-
ogy, USA), TGF-β1 (10 ng/mL) (Gibco-BRL, USA),
tumor necrosis factor-α (TNF-α) (10 ng/mL) (Biosource,
USA), and MG132 (10 μM) (Alexis Corporation,
Switzerland). The proteasome inhibitor MG132 was
added to the medium in the last 12 h to enhance GILZ
visualization when GILZ was analyzed with western blot.
Transfection with lentiviruses expressing GILZ and GR
small hairpin RNA (shRNA)
Lentiviral vectors were generated by co-transfecting
Lenti-X 293 T cells (Clonetech, Belgium) with a pSPAX2
plasmid (Addgene, Plasmid #12260), a VSV-G-encoding
vector, a GILZ (TSC22D3) shRNA plasmid
(#TRCN0000013793 (GILZ shRNA1), #TRCN0000364625
(GILZ shRNA2) or #TRCN0000369187 (GILZ shRNA3),
Sigma-Aldrich, USA), a GR (NR3C1) shRNA plasmid
(#TRCN0000245007 (GR shRNA1), #TRCN0000245003
(GR shRNA2) or #TRCN0000245004 (GR shRNA3),
Sigma-Aldrich, USA), or a non-target sequence-encoding
plasmid (Sigma, Belgium, SHC002). At 72 h post-
transfection, viral supernatants were collected, filtered,
and concentrated 100 × by ultracentrifugation. Lentiviral
vectors were then titrated using a quantitative polymerase
chain reaction (PCR) Lentivirus Titration (Titer) Kit
(ABM, USA, LV900). A total of 5 × 105 synovial fibro-
blasts/well were plated in 24-well plates (BD Biosciences,
USA) and infected with lentiviruses at a multiplicity of in-
fection (MOI) of 30, unless otherwise indicated. After
72 h of incubation, the medium was removed, and the
cells were stimulated.
Enzyme-linked immunosorbent assay (ELISA)
A commercially available sandwich ELISA kit (R&D Sys-
tems, USA) was used to quantify leptin, IL-6, IL-8 and
MMP-1 expression in the culture supernatants. All ex-
periments were performed in triplicate.
Western blotting
Total protein extracts were prepared as described previ-
ously [19]. Ob-R (B-3) (sc-8391), GR (41) (sc-136209),
GILZ (sc-33780) (Santa Cruz Biotechnology, USA), and
glyceraldehyde 3-phosphate dehydrogenase (GAPDH)
(Sigma-Aldrich, USA) primary antibodies were used.
Western blots were visualized with an anti-mouse or
anti-rabbit secondary antibody (Cell Signaling, USA) di-
luted 1/1000 and enhanced chemiluminescence reagents
(GE Healthcare, UK). Western blot band quantification
was performed with Image Studio Lite software (USA),
and protein expression levels were normalized to the
GAPDH level.
Quantitative reverse transcription PCR (RT-qPCR)
Total RNA was isolated from synovial fibroblasts (either
untreated or treated with the indicated concentration of
prednisolone or aldosterone for 5 days) and purified
using a Nucleospin RNA Kit, with rDNAse included
(#740955,). Next, complementary DNA (Cdna) was syn-
thesized by the reverse transcription of 1 μg RNA (in
each reaction) with a RevertAid H Minus First Strand
cDNA Synthesis Kit (#K1632, Thermo Scientific,
Belgium) according to the manufacturer’s instructions.
The resulting cDNA was subsequently PCR amplified
with a KAPA SYBR FAST detection system (#KK4611,
Belgium). Real-time PCR was performed using a Light-
Cycler 480 instrument (Roche, Belgium), and data were
analyzed with LC480 software, release 1.5.0 SP4. cDNA
dilution curves were generated for each gene and were
used to calculate individual real-time PCR efficiencies
(E = 10[−1/slope]). The 2−ΔΔCT method was then used to
calculate the relative gene expression levels between the
untreated (calibrator sample) and treated synovial fibro-
blasts. Input amounts were normalized to the β2-micro-
globulin endogenous control gene. All primers were
purchased from Eurogentec (Belgium). The following
primer sequences were used: leptin, 5′-
AACCCTGTGCGGATTCTTGT-3′ (forward) and 5′-
TCTTGGACTTTTTGGATGGGC-3′ (reverse); GILZ,
5′-GCACAATTTCTCCATCTCCTTCTT-3′ (forward)
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Log transformation was applied to all variables to
normalize their distribution. Statistical analysis was per-
formed using GraphPad Prism software (version 6) by
one-way analysis of variance (ANOVA) for multiple
comparisons, followed by Tukey’s post hoc test. The re-
sults were considered significant at a p value <0.05.
Graphs were constructed using the mean ± standard de-
viation (SD) calculated from three or more independent
experimental replicates for the ELISA, RT-qPCR and
western blot experiments. Independent experiments
were performed using synovial fibroblasts from different
patients (n = 3 or more).
Results
Prednisolone and aldosterone induced GILZ protein
expression through GR in human OA synovial fibroblasts
Human OA synovial fibroblasts were stimulated for
5 days with prednisolone (1 μM) (a glucocorticoid) or al-
dosterone (1 or 10 μM) (a mineralocorticoid). Western
blotting (Fig. 1a) revealed that prednisolone and aldos-
terone induced GILZ expression in these cells.
Glucocorticoids and mineralocorticoids have affinity
for both GR and MR. Therefore, both receptors were in-
vestigated to determine which one is involved in GILZ
expression. Cells were pre-incubated with a GR inhibitor
(5 μM mifepristone) or MR inhibitor (5 μM eplerenone
or 5 μM spironolactone) and were then stimulated for
5 days with prednisolone (1 μM) or aldosterone (1 or
10 μM). The GR inhibitor mifepristone strongly reduced
both prednisolone- and aldosterone-induced GILZ pro-
tein expression (Fig. 1a). In contrast, the MR inhibitors
eplerenone and spironolactone did not significantly
modulate prednisolone-induced or aldosterone-induced
GILZ expression in any experiments (Fig. 1a). These re-
sults suggest that mineralocorticoids and glucocorticoids
induce GILZ expression through GR but not MR in OA
synovial fibroblasts.
To further confirm the involvement of GR in
prednisolone-induced and/or aldosterone-induced GILZ
expression, we performed shRNA experiments to silence
GR. Cells were infected with three different lentiviruses
expressing GR shRNA or with a non-target control lenti-
virus. GR shRNA1, 2 and 3, but not the control shRNA,
reduced endogenous GR expression (Fig. 1b). Two bands
were observed: the antibody was raised against amino
acids 176-289 of GR of human origin. It can therefore
recognize both isoforms and probably other GRα tran-
script splice variants, which could explain the presence of
two large bands. Prednisolone-induced and aldosterone-
induced GILZ expression was reduced when GR was si-
lenced (Fig. 1c). The GR antagonist mifepristone was used
as a positive control to demonstrate GR inactivation.
Thus, we confirmed that glucocorticoid-induced and
mineralocorticoid-induced GILZ expression was GR-
dependent by the silencing of GR.
Leptin and GILZ were similarly modulated; leptin
secretion and Ob-R expression were induced by prednis-
olone and aldosterone through GR
We have previously shown that glucocorticoids enhance
leptin secretion and Ob-R expression in synovial fibro-
blasts ([19] and Fig. 2a: b* vs. a). Similar to prednisolone
(Fig. 2a), the mineralocorticoid aldosterone also induced
leptin secretion and Ob-R protein expression at 1 μM
(Fig. 2b: b* vs. a) and 10 μM (Fig. 2c: b* vs. a). Moreover,
using specific inhibitors (a GR inhibitor (mifepristone)
and MR inhibitors (eplerenone and spironolactone)), we
observed that the prednisolone-induced (Fig. 2a: c* vs.
b*) and aldosterone-induced (Fig. 2b and c: c* vs. b*) lep-
tin secretion and Ob-R expression were GR-dependent
but not MR-dependent in all experiments, as observed
with GILZ. These results suggest that aldosterone in-
duces leptin secretion and Ob-R expression in OA syn-
ovial fibroblasts through GR but not MR, similar to
glucocorticoids. The use of GR and MR antagonists did
not modulate the endogenous level of leptin secretion or
Ob-R expression. Human OA synovial fibroblasts were
then infected with three different lentiviruses expressing
GR shRNA or with a non-target control lentivirus.
Prednisolone-induced and aldosterone-induced leptin
secretion and Ob-R expression were abolished when GR
was silenced (Fig. 3), confirming the involvement of GR
signaling in the induction of these processes.
The induction of leptin by prednisolone and aldoster-
one was dose-dependent (Fig. 4a and b). A dose re-
sponse was observed not only for leptin secretion in the
cell culture supernatant (as measured by ELISA) (Fig. 4a)
but also for leptin messenger RNA (mRNA) expression
(as measured by RT-qPCR) (Fig. 4b). The induction of
leptin by prednisolone was significant at concentrations
of equal to or greater than 10 nM or 1000 nM for ELISA
or RT-qPCR, respectively. However, it was not signifi-
cant at 100 nM or 10 nM for RT-qPCR; although the
mean value was higher than that for the control, the
variance was high. Leptin induction by aldosterone was
significant at concentrations of 100 nM and 1000 nM
for ELISA and RT-qPCR, respectively. The induction of
Ob-R (Fig. 4c) and GILZ (Fig. 4c for western blot and
Fig. 5 for qRT-PCR) by prednisolone and aldosterone
was also dose-dependent, with significant induction at a
concentration equal to or greater than 100 nM.
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Fig. 1 Glucocorticoid-induced leucine zipper (GILZ) expression is induced by prednisolone and aldosterone through glucocorticoid receptor (GR).
a Human osteoarthritis (OA) synovial fibroblasts were pre-incubated or not for 1 h with a GR inhibitor (mifepristone) or mineralocorticoid receptor
(MR) inhibitors (eplerenone and spironolactone) and were then stimulated for 5 days with a glucocorticoid (prednisolone) or a mineralocorticoid
(aldosterone). GILZ and glyceraldehyde 3-phosphate dehydrogenase (GAPDH) expression in whole-cell extracts were analyzed by western blotting.
Right panels, quantification results of western blots shown in left panels. Protein levels were normalized to GAPDH. Graphs represent mean +/- SD
(n = 4 patients). Significance was set at p < 0.05. b*Significantly different from a; c*significantly different from b; d not significantly different from b.
b, c Synovial fibroblasts were infected with three different lentiviruses expressing GR shRNA or with a non-target control lentivirus and were stimulated
or not for 5 days with prednisolone or aldosterone. A GR inhibitor (mifepristone) was used as a positive control for GR inactivation. GILZ,
GR, and GAPDH expression in whole-cell extracts were analyzed by western blotting. Right (b) and upper (c) panels, quantification results
of western blots shown in left panels and lower panels. Protein levels were normalized to GAPDH. Graphs represent mean +/- SD (n = 3
patients). Significance was set at p < 0.05. f*Significantly different from e; h*significantly different from g; i*significantly different from h. kD
kiloDalton, shRNA short hairpin RNA
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TGF-β did not induce GILZ expression, and it de-
creased prednisolone-induced GILZ expression (Fig. 6a),
which is in accordance with our previous results demon-
strating that TGF-β does not induce leptin secretion and
that it decreases glucocorticoid-induced leptin secretion
[20]. Moreover, the selective GR agonist CpdA, which
does not induce leptin expression [23], also does not in-
duce GILZ expression (Fig. 6b). Taken together, these re-
sults indicate that leptin and GILZ have similar
expression profiles, suggesting correlation between their
expression.
GILZ was involved in prednisolone-induced and
aldosterone-induced leptin and Ob-R expression
ShRNA experiments for the silencing of GILZ expres-
sion were performed to determine whether GILZ is in-
volved in prednisolone- and/or aldosterone-induced
leptin secretion. Human OA synovial fibroblasts were
infected with three different lentiviruses expressing
GILZ shRNA or with a non-target control lentivirus.
After 72 h of incubation, the medium was removed, and
the cells were stimulated with prednisolone (1 μM) or
aldosterone (1 or 10 μM). GILZ shRNA reduced GILZ
Fig. 2 Leptin secretion and leptin receptor (Ob-R) expression were induced by prednisolone and aldosterone through glucocorticoid receptor
(GR) signaling. Human osteoarthritis (OA) synovial fibroblasts were pre-incubated or not for 1 h with a GR inhibitor (mifepristone) or
mineralocorticoid receptor (MR) inhibitors (eplerenone and spironolactone) and were then stimulated for 5 days with a glucocorticoid
(prednisolone) (A) or mineralocorticoid (aldosterone) (B, C). Leptin expression was measured in cell culture supernatants by ELISA. Ob-R and
glyceraldehyde 3-phosphate dehydrogenase (GAPDH) expression in whole-cell extracts were analyzed by western blotting. Upper panels (right),
quantification results of western blots shown in bottom panels. Proteins levels were normalized to GAPDH. Graphs represent mean +/- SD
(n = 3 or 4 patients). Significance set at p < 0.05. b*Significantly different from a; c*significantly different from b; d not significantly different
from b. kD kiloDalton
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expression following prednisolone (Fig. 7a) or aldoster-
one (Fig. 7b) stimulation. Downregulation of GILZ ex-
pression resulted in significant decreases in
prednisolone-induced (Fig. 7a) and aldosterone-induced
(Fig. 7b) leptin and Ob-R expression compared with the
controls. These decreases were correlated with the
shRNA MOI and with the degree of GILZ silencing
(Fig. 7c). GILZ silencing did not alter GR expression or
prednisolone-induced GR degradation (Fig. 8).
GILZ inhibition did not alter the anti-inflammatory
properties of prednisolone
Synovial fibroblasts spontaneously produced the pro-
inflammatory cytokines IL-6, IL-8 and MMP-1, and cell
stimulation by TNF-α enhanced the secretion of these
cytokines (Fig. 9a-c). Human OA synovial fibroblasts
were infected with three different lentiviruses expressing
GILZ shRNA or with a non-target control lentivirus.
Cells were pre-incubated (Fig. 9d-f ) or not (Fig. 9a-c) for
1 h with prednisolone (1 μM) and were then stimulated
or not with TNF-α (10 ng/mL) for 12 h. GILZ-shRNA
did not significantly alter TNF-α-induced IL-6, IL-8 and
MMP-1 production (Fig. 9a-c). Moreover, GILZ inhib-
ition did not alter the capacity for prednisolone to re-
duce the TNF-α-induced production of these cytokines
(Fig. 9d-f ). These results suggest that GILZ is not an
essential mediator of the anti-inflammatory activities of
glucocorticoids in OA synovial fibroblasts.
Discussion
Glucocorticoids are widely used by rheumatologists, ei-
ther to treat a flare in inflammatory rheumatic diseases
or to reduce pain and swelling through intra-articular in-
jection into joints in OA [29]. Unfortunately, they also
contribute to adverse events, such as diabetes mellitus
and osteoporosis. Moreover, glucocorticoids enhance a
catabolic reaction leading to the degradation of cartilage
Fig. 3 Leptin secretion and leptin receptor (Ob-R) expression were induced by prednisolone and aldosterone through glucocorticoid receptor
(GR) signaling. Synovial fibroblasts were infected with three different lentiviruses expressing GR short hairpin RNA (shRNA) or with a non-target
control lentivirus and were stimulated for 5 days with prednisolone or aldosterone. The GR inhibitor mifepristone was used as a positive control
for GR inhibition. Leptin expression was measured in the cell culture supernatants by ELISA. Ob-R and glyceraldehyde 3-phosphate dehydrogenase
(GAPDH) expression were analyzed in whole-cell extracts by western blotting. Middle panel, quantification results of western blots shown in the lower
panel. Protein levels were normalized to GAPDH. Graphs represent mean +/- SD (n = 3 patients). Significance was set at p < 0.05. b*Significantly
different from a; c*significantly different from b*. kD kiloDalton
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[30], and they suppress matrix protein markers of chon-
drogenic differentiation [31].
GILZ is an intracellular protein induced by glucocorti-
coids and is mainly present in immune cells [32–34]. It
can also be induced by mineralocorticoids, as observed
in kidney cells [28]. Beaulieu et al. have observed GILZ
expression in the synovium of patients with rheumatoid
arthritis and in cultured rheumatoid arthritis synovial
fibroblasts and have found that its expression is en-
hanced by dexamethasone and significantly reduced
Fig. 4 Leptin secretion and leptin receptor (Ob-R) and glucocorticoid-induced leucine zipper (GILZ) expression were dose-dependent. a, b Human
osteoarthritis (OA) synovial fibroblasts were stimulated for 5 days with increasing concentrations of a glucocorticoid (prednisolone) or mineralocorticoid
(aldosterone). Leptin secretion was measured in the cell culture supernatants by ELISA, and leptin messenger RNA (mRNA) expression was measured
by RT-qPCR. Graphs represent mean +/- SD (n = 4 or 5 patients). Significance was set at p < 0.05. b*Significantly different from a; c not significantly
different from a; e*significantly different from d; f not significantly different from d. c Human OA synovial fibroblasts were stimulated for 5 days with
increasing concentrations of a glucocorticoid (prednisolone) or mineralocorticoid (aldosterone). Ob-R, GILZ and glyceraldehyde 3-phosphate
dehydrogenase (GAPDH) expression in whole-cell extracts were analyzed by western blotting. Right panels, quantification results of western
blots shown in the left panels. Protein levels were normalized to GAPDH. Graphs represent mean +/- SD (n = 3 patients). Significance was set
at p < 0.05. h*Significantly different from g; i not significantly different from g
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by mifepristone, suggestive of GR involvement [8]. Our
work extends the presence of GILZ to human OA synovial
fibroblasts and demonstrates for the first time that both
the glucocorticoid prednisolone and the mineralocorticoid
aldosterone induce GILZ expression in these cells in a
dose-dependent and GR-dependent process, at the protein
and the mRNA level.
We propose a novel role of GILZ in contributing to
corticoid-induced leptin and Ob-R expression in OA
synovial fibroblasts. Indeed, we have previously reported
that human OA synovial fibroblasts produce leptin (a
pro-inflammatory adipokine involved in OA pathogen-
esis) and its receptor, Ob-R, both spontaneously and
after stimulation with glucocorticoids [19]. We have also
Fig. 5 Glucocorticoid-induced leucine zipper (GILZ) expression under prednisolone and aldosterone stimulation was dose dependent. Human
osteoarthritis (OA) synovial fibroblasts were stimulated for 5 days with increasing concentrations of a glucocorticoid (prednisolone) or mineralocorticoid
(aldosterone). GILZ messenger RNA (mRNA) expression was measured by RT-qPCR. Graphs represent mean +/- SD (n = 4 patients). Significance was set
at p < 0.05. b*Significantly different from a; c not significantly different from a
A
B
Fig. 6 Transforming growth factor-β (TGF-β) decreased both prednisolone-induced leptin secretion and glucocorticoid-induced leucine zipper
(GILZ) expression; Compound A (CpdA) did not induce GILZ expression. Human osteoarthritis (OA) synovial fibroblasts were stimulated for
5 days with prednisolone, TGF-β (A), or CpdA (B). Leptin expression was measured in the cell culture supernatants by ELISA. GILZ and glyceraldehyde
3-phosphate dehydrogenase (GAPDH) expression in whole-cell extracts was analyzed by western blotting. Right panels, quantification results of western
blots shown in the left panels. Protein levels were normalized to GAPDH. Graphs represent mean +/- SD (n = 3 patients). b*Significantly different from
a; c*significantly different from b; e*significantly different from d; f not significantly different from d
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Fig. 7 Glucocorticoid-induced leucine zipper (GILZ) silencing inhibited glucocorticoid-induced and mineralocorticoid-induced leptin and leptin
receptor (Ob-R) expression. Human osteoarthritis (OA) synovial fibroblasts were infected with three different lentiviruses expressing GILZ short
hairpin RNA (shRNA) or with a control lentivirus (multiplicity of infection (MOI) 30 for a and b; MOI 5, 10 and 20 for c). After 72 h, the cells were
stimulated for 5 days with a glucocorticoid (1 μM prednisolone) or mineralocorticoid (10 μM aldosterone). Leptin expression was measured in the
cell culture supernatants by ELISA. Ob-R, GILZ and glyceraldehyde 3-phosphate dehydrogenase (GAPDH) expression in whole-cell extracts was
analyzed by western blotting. Right panels, quantification results of western blots shown in the left panels. Protein levels were normalized to
GAPDH. Graphs represent mean +/- SD (n = 5 patients). b*Significantly different from a; c*significantly different from b. kD kiloDalton
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previously demonstrated that leptin induction occurs in-
dependently of any adipogenesis-related processes by
performing oil red staining and that it occurs in the ab-
sence of adipogenic mediators [19]. Among adipokines,
leptin is of particular interest in metabolic OA, as we
did not detect any endogenous or glucocorticoid-
induced secretion of resistin or adiponectin in OA syn-
ovial fibroblasts [23]. The deleterious contribution of
leptin to the pathogenesis of metabolic OA [15] indi-
cates that leptin and Ob-R expression in synovial fibro-
blasts contribute to the adverse metabolic events caused
by glucocorticoids. GILZ, leptin and Ob-R protein ex-
pression are closely correlated, as demonstrated by the
significant reductions in leptin and Ob-R expression fol-
lowing GILZ silencing.
Moreover, we previously reported that TGF-β reduced
the prednisolone-induced leptin secretion through
ALK5-Smad2/3 [20]. In this work, we observed that
TGF-β did not induce GILZ and reduced the
prednisolone-induced GILZ expression, which is coher-
ent with our previous results. This is also coherent with
previous works in human bronchial epithelial cells,
where TGF-β1 impaired the glucocorticoid trans-
activation, did not induce GILZ mRNA and even
reduced dexamethasone-induced GILZ expression also
through ALK5-Smad2/3 [35].
GILZ is primarily described as a mediator of the anti-
inflammatory activities of glucocorticoids in immune-
related cells [32–34]. GILZ overexpression has signifi-
cant anti-inflammatory effects in the treatment of
collagen-induced arthritis [9, 10]. However, in the
current study, GILZ depletion in OA synovial fibroblasts
did not alter either the TNF-α-induced pro-
inflammatory protein levels (IL-6, IL-8, and MMP-1) or
the capacity for glucocorticoids to downregulate the
TNF-α-induced production of IL-6, IL-8, and MMP-1,
supporting the notion that GILZ is not significantly in-
volved in the anti-inflammatory regulation of glucocorti-
coids in OA. GILZ downregulation did not modulate GR
expression or GR downregulation. A lack of inflamma-
tory modulation in synovial cells following GILZ down-
regulation has also been reported in mouse models of
collagen-induced arthritis [9] and in human umbilical
venous endothelial cells [10]. Last, although Beaulieu
et al. [8] have previously shown that GILZ overexpres-
sion significantly inhibits the production of key pro-
inflammatory cytokines, such as IL-6 and IL-8, in
rheumatoid arthritis synovial fibroblasts, it has no effect
on a panel of additional pro-inflammatory cytokines,
such as IL-1β, TNF-α, and IL-12p70, which are pro-
duced by the same cells. Thus, involvement of GILZ in
the inflammatory process appears to be cell-dependent.
In this study, we showed that the SEGRA CpdA
(which activates only the trans-repression pathway and
has a better benefit-risk ratio than glucocorticoids [22])
did not induce GILZ expression. This finding is consist-
ent with our previous study showing that CpdA does
not induce leptin secretion or Ob-R expression and that
it exhibits similar anti-inflammatory effects to classical
glucocorticoids [23], positioning the leptin secretion in
the trans-activation pathway. While GILZ is not neces-
sary for the glucocorticoid anti-inflammatory effect and
is involved in leptin secretion, absence of GILZ induc-
tion by CpdA seems coherent. This result is also in
Fig. 8 Glucocorticoid-induced leucine zipper (GILZ) silencing did not alter prednisolone-induced glucocorticoid receptor (GR) degradation. Human
osteoarthritis (OA) synovial fibroblasts were infected with a lentivirus expressing GILZ short hairpin RNA (shRNA) or with a control lentivirus. After
72 h, the cells were stimulated for 1, 4, 6, or 12 h with a glucocorticoid (1 μM prednisolone). Leptin expression was measured in the cell culture
supernatants by ELISA. GILZ and glyceraldehyde 3-phosphate dehydrogenase (GAPDH) expression in whole-cell extracts was analyzed by western
blotting. Upper panel, quantification results of western blot shown in the lower panel. Protein levels were normalized to GAPDH. Graph represents
mean +/- SD (n = 3) patients. kD kiloDalton
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agreement with Drebert et al., who have demonstrated a
lack of GILZ induction under CpdA treatment in colon-
cancer-derived myofibroblasts [36] and with Gavrila
et al. using airway smooth muscle cells [37]. Moreover,
other authors have demonstrated that CpdA does not in-
duced DUSP1, which is another actor in the glucocortic-
oid trans-activation [38].
From a metabolic point of view, it can be hypothesized
that GILZ induction is deleterious in OA because it in-
duces the adipokine leptin. Additional examples of the
involvement of GILZ in glucocorticoid-associated ad-
verse events have been reported. Dexamethasone and
GILZ have been shown to inhibit the repair of respira-
tory epithelial cells [39]. In addition, the long-term use
Fig. 9 Glucocorticoid-induced leucine zipper (GILZ) inhibition did not alter the capacity for prednisolone to reduce IL-6, IL-8 and matrix
metalloproteinase-1 (MMP-1) production. Human osteoarthritis (OA) synovial fibroblasts were infected with three different lentiviruses
expressing GILZ short hairpin RNA (shRNA) or with a control lentivirus (one sample was infected with one shRNA and the three results
were pooled). Cells were pre-incubated (D, E, F) or not (A, B, C) for 1 h with prednisolone (1 μM) and were then stimulated or not with TNF-α (10 ng/mL)
for 12 h. The IL-6, IL-8 and MMP-1 levels in the cell culture supernatants were measured by ELISA. Graphs represent mean +/- SD (n = 3
patients). Fold reductions in IL-6, IL-8, and MMP-1 induced by TNF-α were measured by comparing the levels in the presence or not of
prednisolone (1 μM). b*Significantly different from a; c not significantly different from b; e f not significantly different from d
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of glucocorticoids has been demonstrated to have anti-
myogenic effects due to the presence of GILZ as an
effector [40].
In the present study, aldosterone, a mineralocorticoid,
was also found to be a significant stimulator of GILZ,
leptin, and Ob-R expressions. These results are in ac-
cordance with those of previous studies showing an
in vitro increase in the leptin mRNA level in brown adi-
pose tissue after aldosterone exposure [27] and higher
circulating leptin levels in patients with primary hyperal-
dosteronism [41]. Aldosterone is known for its associ-
ation with a bad metabolic profile (i.e., its association
with the development of metabolic syndrome in
humans) [42, 43] and for its aggravation of glucose in-
tolerance by high fructose in rats [44]. It is also present
in the synovial fluid of patients with OA [45]. Therefore,
targeting the aldosterone pathway could be promising
for the treatment of OA.
Corticoid concentrations in synovial fluid have not
been well-described. With regard to glucocorticoids, hu-
man OA synovial fluid has been reported to contain 125
nM cortisol [45]. Significant induction of leptin, Ob-R,
and GILZ expression has been observed at this concen-
tration by prednisolone (a synthetic cortisol compound).
Accordingly, the significant effect of glucocorticoids on
leptin production in the joints in OA may be clinically
relevant, even in the absence of exogenous glucocortic-
oid administration. However, the mineralocorticoid
levels are 1000-fold decreased in biologic fluids com-
pared to the glucocorticoid levels. Although 1 μM
aldosterone has been used in studies with mechanistic
models [25], the physiological concentration is approxi-
mately 100 pM in OA synovial fluid [45], which was not
sufficient to induce leptin or Ob-R expression in our
model. Therefore, we cannot affirm that leptin and GILZ
induction by aldosterone is clinically relevant. However,
the use of 1 μM and 10 μM aldosterone in the current
study confirmed the focus of our mechanistic model on
the role of GILZ in leptin expression.
The influence of aldosterone on GILZ, leptin and Ob-
R expressions is also GR-dependent; indeed, their induc-
tion remains unchanged in the presence of specific MR
inhibitors, whereas it is abolished in the presence of spe-
cific GR inhibitors or after GR silencing. Lee et al. have
observed that GR silencing blocks leptin induction by
cortisol in human adipocytes, in contrast with MR silen-
cing [46]. Leminen et al. have demonstrated in vivo
downregulation of the expression of circulating leptin in
humans with the GR inhibitor mifepristone [47]. How-
ever, the regulation of leptin by aldosterone appears to
be tissue-dependent, and it requires further clarification.
In mice with impaired leptin receptor signaling, MR
blockade by eplerenone administration in vivo has been
shown to reduce leptin mRNA expression in retroperi-
toneal adipose tissue [48].
Conclusion
In conclusion, we describe a new role for GILZ in the
corticoid-induced leptin and Ob-R expression in OA
synovial fibroblasts. Absence of GILZ prevents
corticoid-induced leptin secretion and Ob-R expression
without modulating the anti-inflammatory properties of
glucocorticoids in OA synovial fibroblasts (Fig. 10). Re-
garding the deleterious involvement of leptin in OA
pathogenesis, the use of GR agonists that do not activate
GILZ pathways when using glucocorticoids should be
evaluated.
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Fig. 10 Absence of glucocorticoid-induced leucine zipper (GILZ)
prevented the corticoid-induced leptin and leptin receptor (Ob-R)
expression without modulating the anti-inflammatory properties
of glucocorticoids. Prednisolone and aldosterone induced GILZ
expression in OA synovial fibroblasts through glucocorticoid receptor
(GR) but not mineralocorticoid receptor (MR) activation, whereas
Compound A (CpdA) did not. Similar effects on leptin secretion and
Ob-R expression were observed. Thus, GILZ was involved in
prednisolone-induced and aldosterone-induced leptin secretion
and Ob-R expression. In addition, GILZ inhibition did not alter
the anti-inflammatory action of prednisolone
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